Literature DB >> 15103688

Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.

A Polyzou1, S Pournaras, U Dafni, D Sofianou, E Christeli, S Patrinos, A Tsakris.   

Abstract

A seroepidemiological study was conducted on a representative sample of the northern Greek population (healthy individuals, age range=1 day to 80 years) to assess the prevalence of antibodies to pertussis toxin (PT) and filamentous hemagglutinin (FHA). Antibody concentrations were significantly elevated with age (analysis of variance (ANOVA), P<0.001). In addition, a significant increase in antibody levels was detected in subjects >50 years old compared to children aged 5-10 years (post-hoc Scheffe analysis, P=0.007). These data suggest that pertussis occurs frequently in Greek adults, and that sometimes a fifth booster vaccine dose is not given after the second year of life. Routine revaccination with the acellular vaccine for children >4 years of age, adolescents, and adults should be considered in order to ensure effective protection of the whole population. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103688      PMCID: PMC6807800          DOI: 10.1002/jcla.20025

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  15 in total

Review 1.  Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.

Authors:  J R Kerr; R C Matthews
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-02       Impact factor: 3.267

2.  Etiology of respiratory tract infection in adults in a general practice setting.

Authors:  D Lieberman; P Shvartzman; D Lieberman; M Ben-Yaakov; Z Lazarovich; S Hoffman; R Mosckovitz; B Ohana; M Leinonen; D Luffy; I Boldur
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-10       Impact factor: 3.267

3.  Assessment of vaccine coverage of schoolchildren in three primary health care areas in rural Crete, Greece.

Authors:  C Lionis; M Chatziarsenis; N Antonakis; Y Gianoulis; M Fioretos
Journal:  Fam Pract       Date:  1998-10       Impact factor: 2.267

4.  The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.

Authors:  L A Cattaneo; G W Reed; D H Haase; M J Wills; K M Edwards
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

5.  Identification of immunodominant epitopes in the filamentous hemagglutinin of Bordetella pertussis.

Authors:  G Piatti
Journal:  FEMS Immunol Med Microbiol       Date:  1999-03

6.  Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study.

Authors:  P García-Corbeira; R Dal-Ré; L Aguilar; J García-de-Lomas
Journal:  Vaccine       Date:  2000-04-28       Impact factor: 3.641

7.  Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection.

Authors:  S Stojanov; J Liese; B H Belohradsky
Journal:  Infection       Date:  2000 Mar-Apr       Impact factor: 3.553

8.  Morbidity of pertussis in adolescents and adults.

Authors:  G De Serres; R Shadmani; B Duval; N Boulianne; P Déry; M Douville Fradet; L Rochette; S A Halperin
Journal:  J Infect Dis       Date:  2000-06-30       Impact factor: 5.226

9.  Seroepidemiology of pertussis in Italy.

Authors:  A Giammanco; A Chiarini; T Stroffolini; D De Mattia; M Chiaramonte; M E Moschen; I Mura; G Rigo; S Taormina; A Sarzana
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

10.  Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production.

Authors:  M Leef; K L Elkins; J Barbic; R D Shahin
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  3 in total

1.  Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy.

Authors:  G Gabutti; M Bergamini; P Bonanni; M Guido; D Fenoglio; A Giammanco; L Sindoni; C Zotti; V Boddi; F Bamfi; R Severini; A Bechini; S Boccalini; P Crovari
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

2.  Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.

Authors:  Maja Socan; Katarina Prosenc; Miljana Vegnuti
Journal:  Wien Klin Wochenschr       Date:  2006-06       Impact factor: 1.704

3.  Toll-like receptor 4 limits transmission of Bordetella bronchiseptica.

Authors:  Olivier Rolin; Will Smallridge; Michael Henry; Laura Goodfield; David Place; Eric T Harvill
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.